Global and societal implications of the diabetes epidemic

Nature

Volumn 414, Issue 6865, 2001, Pages 782-787

  Zimmet, Paul ^a   Alberti, K G M M ^b   Shaw, Jonathan ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; NUTRITION; SOCIAL ASPECTS;

HUMAN BEHAVIOR;

EPIDEMIOLOGY;

DIABETES; DISEASE INCIDENCE; EPIDEMIC; LIFESTYLE;

BEHAVIOR MODIFICATION; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; GENETIC SUSCEPTIBILITY; HUMAN; LIFESTYLE; MORBIDITY; MORTALITY; NUTRITION; OBESITY; PRIORITY JOURNAL; REVIEW; SITTING;

ADOLESCENT; ADULT; ANIMALS; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE OUTBREAKS; FORECASTING; GLUCOSE INTOLERANCE; HUMANS; METABOLIC SYNDROME X; PREVALENCE; SOCIOLOGY; WORLD HEALTH;

EID: 0035856920     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/414782a     Document Type: Review

References (78)

1. Globalization, coca-colonization and the chronic disease epidemic: Can the doomsday scenario be averted?
2. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010
3. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections
4. Redefining type 2 diabetes: 'Diabesity' or 'obesity dependent diabetes mellitus'?
5. Development and consequences of insulin resistance: Lessons from animals with hyperinsulinaemia
6. Diabetes epidemiology as a trigger to diabetes research
7. Economic consequences of diabetes mellitus in the U.S. in 1997
8. Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective
9. Type 2 diabetes in children
10. The economic costs of NIDDM
11. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
12. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
13. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
14. Heart Outcomes Prevention Evaluation (HOPE) Study. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and MICRO-HOPE substudy
15. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus a randomized prospective 6-year study
16. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
17. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
18. The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography
19. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study
20. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
21. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality
22. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data
23. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study
24. Impaired glucose tolerance. Why is it not a disease?
25. The changing face of macrovascular disease in non-insulin dependent diabetes mellitus in different cultures: An epidemic in progress
26. Impaired glucose tolerance - Fact or fiction
27. Report of the Expert Committee
28. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius
29. The molecular genetics of non-insulin dependent diabetes mellitus
30. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset on clinical diabetes?
31. Role of insulin resistance in human disease
32. Cardiovascular morbidity and mortality associated with the metabolic syndrome
33. Emerging epidemic of type 2 diabetes in youth
34. Type 2 diabetes in children and adolescents
35. Type 2 diabetes mellitus in UK children - An emerging problem
36. Increased incidence of non-insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal protein and fat
37. Decline in incidence of epidemic glucose intolerance in Nauruans: Implications for the thrifty genotype
38. Crucial points at diagnosis - NIDDM or slow IDDM
39. Rising prevalence of NIDDM in an urban population in India
40. Westernisation, insulin resistance and diabetes in Australian Aborigines
41. The epidemiology and natural history of NIDDM - Lessons from the South Pacific
42. Prevalence of diabetes and ethnic differences in cardiovascular risk factors
43. Community-based epidemiological study on diabetes in Pu-Li, Taiwan
44. Prevalence of diabetes and its risk factors in China
45. Kelly West lecture 1991. Challenges in diabetes epidemiology - From west to the rest
46. Diabetes mellitus: A thrifty genotype rendered detrimental by "progress"?
47. The thrifty genotype in non-insulin-dependent diabetes. The hypothesis survives
48. Beacon: A novel gene involved in the regulation of energy balance
49. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis
50. The nutritional basis of the fetal origins of adult disease
51. The fetal insulin hypothesis: An alternative explanation of the association of low birthweight with diabetes and vascular disease
52. Review of the evidence on fetal and early childhood antecedents of adult chronic disease
53. The global NIDDM epidemic. Treating the disease and ignoring the symptom
54. Design and methods for a clinical trial in the prevention of type 2 diabetes
55. Diet and exercise delay onset of type 2 diabetes, say US experts
56. Overview of 6 years' therapy of type 11 diabetes: A progressive disease (UKPDS 16)
57. Plasma insulin response among Nauruans: Prediction of deterioration in glucose tolerance over 6 yrs
58. Stemming the tide of diabetes mellitus
59. Public-health priorities in the industrialised world
60. Scientists battle obesity overload
61. US public health and the 21st century: Diabetes mellitus
62. The pathogenesis of insulin-dependent diabetes mellitus
63. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus
64. Epidemiology of childhood diabetes mellitus in Finland - Background o fa nationwide study of type 1 diabetes (insulin dependent) diabetes mellitus
65. Comparison of the incidence of insulin dependent diabetes mellitus among five Baltic populations during 1983-1988
66. Comparison of incidence of IDDM in childhood between Estonia and Finland, 1980-1988
67. Dietary microbial toxins and type 1 diabetes - A new meaning for seed and soil
68. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ cells